Does VALSARTAN Cause Aplastic anaemia? 51 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Aplastic anaemia have been filed in association with VALSARTAN (valsartan). This represents 0.2% of all adverse event reports for VALSARTAN.
51
Reports of Aplastic anaemia with VALSARTAN
0.2%
of all VALSARTAN reports
0
Deaths
43
Hospitalizations
How Dangerous Is Aplastic anaemia From VALSARTAN?
Of the 51 reports, 43 (84.3%) required hospitalization.
Is Aplastic anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALSARTAN. However, 51 reports have been filed with the FAERS database.
What Other Side Effects Does VALSARTAN Cause?
Drug ineffective (1,845)
Blood pressure increased (1,682)
Dizziness (1,527)
Headache (1,361)
Hypertension (1,341)
Acute kidney injury (1,301)
Dyspnoea (1,239)
Fatigue (1,156)
Malaise (1,139)
Hypotension (1,032)
What Other Drugs Cause Aplastic anaemia?
ECULIZUMAB (345)
CYCLOPHOSPHAMIDE (332)
CYCLOSPORINE (331)
METHOTREXATE (281)
BUSULFAN (220)
FLUDARABINE (220)
ETOPOSIDE (186)
VINCRISTINE (173)
CYTARABINE (163)
ELTROMBOPAG OLAMINE (149)
Which VALSARTAN Alternatives Have Lower Aplastic anaemia Risk?
VALSARTAN vs VALTREX
VALSARTAN vs VAMOROLONE
VALSARTAN vs VANCOMYCIN
VALSARTAN vs VANDETANIB
VALSARTAN vs VARDENAFIL